Article
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.
Journal of the National Comprehensive Cancer Network : JNCCN - 18 Jun 2024
Rosso Claudia, Marciano Naomie Devico, Nathan Deepika, Chen Wen-Pin, McLaren Christine E, Osann Kathryn E, Flodman Pamela L, Cho May T, Lee Fa-Chyi, Dayyani Farshid, Zell Jason A, Valerin Jennifer B
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year overall survival rate of 10%. In November 2018, NCCN recommended that all patients with PDAC receive genetic counseling (GC) and germline testing regardless of family history. We hypothesized that patients with PDAC were more likely to be referred for testing after this change to the guidelines, regardless of presumed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
